share_log

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Burnett Patrick

SEC announcement ·  Mar 6 17:16
Summary by Moomoo AI
Patrick Burnett, associated with Arcutis Biotherapeutics, Inc. [ARQT], completed a sale of company stock on March 4, 2024. The transaction involved the disposal of 4,782 shares of common stock at a price of $11.1212 per share. Following the sale, Burnett's direct holdings in the company amount to 269,300 shares. The total value of the shares sold is approximately $53,181.58. This sale was executed in the open market and is part of the normal course of investment transactions.
Patrick Burnett, associated with Arcutis Biotherapeutics, Inc. [ARQT], completed a sale of company stock on March 4, 2024. The transaction involved the disposal of 4,782 shares of common stock at a price of $11.1212 per share. Following the sale, Burnett's direct holdings in the company amount to 269,300 shares. The total value of the shares sold is approximately $53,181.58. This sale was executed in the open market and is part of the normal course of investment transactions.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more